The Gift That Keeps On Giving (To Defendants)

Law360, New York (December 20, 2013, 6:04 PM EST) -- On Dec. 2, 2013, the Sixth Circuit joined a number of its sister courts and broadly applied PLIVA v. Mensing, further stifling the ability to maintain claims against generic drug manufacturers on a failure-to-warn theory. In so doing, the Sixth Circuit added another nugget to defendants' ever-growing Mensing goldmine.

When the U.S. Supreme Court decided Mensing in 2011, and held that state law failure-to-warn claims against generic drug manufacturers were preempted by federal law, defendant drug manufacturers knew they had won a major victory. But the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.